Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Cystic fibrosis

Original research

Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study

Online download statistics by month:

Online download statistics by month: February 2021 to March 2024

	Abstract	Full	Pdf
Feb 2021	1313	65	48
Mar 2021	1190	34	27
Apr 2021	384	38	36
May 2021	220	21	12
Jun 2021	32	17	11
Jul 2021	11	9	7
Aug 2021	30	23	18
Sep 2021	43	35	25
Oct 2021	452	22	31
Nov 2021	351	13	14
Dec 2021	160	10	8
Jan 2022	172	13	8
Feb 2022	313	9	7
Mar 2022	286	12	13
Apr 2022	171	3	5
May 2022	338	12	10
Jun 2022	369	33	39
Jul 2022	174	11	16
Aug 2022	171	12	19
Sep 2022	198	10	16
Oct 2022	318	15	16
Nov 2022	102	9	6
Dec 2022	63	3	7
Jan 2023	85	15	10
Feb 2023	148	14	10
Mar 2023	74	5	5
Apr 2023	59	7	3
May 2023	101	10	13
Jun 2023	43	6	4
Jul 2023	113	8	5
Aug 2023	91	10	4
Sep 2023	112	2	8
Oct 2023	96	11	5
Nov 2023	110	14	13
Dec 2023	131	10	6
Jan 2024	124	12	15
Feb 2024	59	5	4
Mar 2024	70	15	8
Total	8277	573	512